Pricing Log in Create free account

Minerva Neurosciences, Inc (NERV) vs Spruce Biosciences, Inc. (SPRB)

Minerva Neurosciences, Inc and Spruce Biosciences, Inc. are both Biotechnology companies. Minerva Neurosciences, Inc and Spruce Biosciences, Inc. are of similar size ($119.2M and $115.6M). Across the 9 metrics below, Spruce Biosciences, Inc. leads on 5 and Minerva Neurosciences, Inc on 4.

Valuation

Metric NERV SPRB Biotechnology median
P/E n/m n/m 8.50
P/S n/m 19.63 9.71
P/B n/m 1.15 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 1.46 9.21
Earnings yield (1,207.23%) (100.33%) (33.15%)
Free cash flow yield (24.00%) (44.38%) (25.50%)

Profitability

Metric NERV SPRB Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 322.05% (105.98%) (56.36%)
Return on assets (629.71%) (82.38%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NERV SPRB Biotechnology median
Revenue growth (TTM) — (51.32%) 6.02%
EPS growth (last fiscal year) (18,347.37%) 47.59% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NERV SPRB Biotechnology median
Debt to equity 0.00 0.08 0.00
Current ratio 20.14 9.23 4.72
Net debt to EBITDA 5.46 1.34 0.96

Dividend

Metric NERV SPRB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NERV SPRB Biotechnology median
Market cap 115.55m 119.19m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack